NO154426C - Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater. - Google Patents

Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.

Info

Publication number
NO154426C
NO154426C NO802056A NO802056A NO154426C NO 154426 C NO154426 C NO 154426C NO 802056 A NO802056 A NO 802056A NO 802056 A NO802056 A NO 802056A NO 154426 C NO154426 C NO 154426C
Authority
NO
Norway
Prior art keywords
chinazolin
oxo
preparation
acid derivatives
new therapeutic
Prior art date
Application number
NO802056A
Other languages
English (en)
Norwegian (no)
Other versions
NO802056L (no
NO154426B (no
Inventor
Ronald Andrew Lemahieu
William Chester Nason
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO802056L publication Critical patent/NO802056L/no
Publication of NO154426B publication Critical patent/NO154426B/no
Publication of NO154426C publication Critical patent/NO154426C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO802056A 1979-07-09 1980-07-08 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater. NO154426C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5572879A 1979-07-09 1979-07-09
US06/142,903 US4281127A (en) 1979-07-09 1980-04-23 Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives

Publications (3)

Publication Number Publication Date
NO802056L NO802056L (no) 1981-01-12
NO154426B NO154426B (no) 1986-06-09
NO154426C true NO154426C (no) 1986-09-17

Family

ID=26734565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802056A NO154426C (no) 1979-07-09 1980-07-08 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.

Country Status (21)

Country Link
US (1) US4281127A (pt)
EP (1) EP0023594B1 (pt)
AR (1) AR226854A1 (pt)
AU (1) AU521014B2 (pt)
CA (1) CA1134825A (pt)
DE (1) DE3067830D1 (pt)
DK (1) DK150483C (pt)
ES (2) ES8106302A1 (pt)
FI (1) FI74279C (pt)
GR (1) GR65952B (pt)
HK (1) HK52187A (pt)
HU (1) HU184797B (pt)
IE (1) IE49938B1 (pt)
IL (1) IL60514A (pt)
MC (1) MC1333A1 (pt)
NO (1) NO154426C (pt)
NZ (1) NZ194259A (pt)
PH (1) PH16413A (pt)
PT (1) PT71512B (pt)
SG (1) SG20887G (pt)
YU (1) YU42348B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599336A (en) * 1983-08-08 1986-07-08 Hoffmann-La Roche Inc. Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide
GB9404485D0 (en) 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
US6706721B1 (en) * 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7087613B2 (en) * 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
JP2005529076A (ja) * 2002-02-15 2005-09-29 サイトキネティクス・インコーポレーテッド キナゾリノンの合成
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
MXPA04011074A (es) * 2002-05-09 2005-06-08 Cytokinetics Inc Compuestos de pirimidinona, composiciones y metodos.
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
AU2003236527A1 (en) * 2002-06-14 2003-12-31 Cytokinetics, Inc. Compounds, compositions, and methods
US7211580B2 (en) * 2002-07-23 2007-05-01 Cytokinetics, Incorporated Compounds, compositions, and methods
JP2005536553A (ja) * 2002-08-21 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
WO2004034972A2 (en) * 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
US20050197327A1 (en) * 2003-11-03 2005-09-08 Gustave Bergnes Compounds, compositions, and methods
US20050148593A1 (en) * 2003-11-07 2005-07-07 Gustave Bergnes Compounds, compositions, and methods
US7439254B2 (en) * 2003-12-08 2008-10-21 Cytokinetics, Inc. Compounds, compositions, and methods
UY29198A1 (es) * 2004-11-09 2006-05-31 Cancer Rec Tech Ltd Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786055A (en) * 1955-02-10 1957-03-19 Mallinckrodt Chemical Works Carboxyalkyl-iodoquinazolones
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones

Also Published As

Publication number Publication date
IL60514A (en) 1985-03-31
YU42348B (en) 1988-08-31
PT71512A (en) 1980-08-01
IE49938B1 (en) 1986-01-08
MC1333A1 (fr) 1981-04-21
FI74279C (fi) 1988-01-11
EP0023594B1 (de) 1984-05-16
FI74279B (fi) 1987-09-30
HK52187A (en) 1987-07-17
AR226854A1 (es) 1982-08-31
NO802056L (no) 1981-01-12
ES493203A0 (es) 1981-05-16
DK294780A (da) 1981-01-10
CA1134825A (en) 1982-11-02
IL60514A0 (en) 1980-09-16
GR65952B (pt) 1981-01-09
ES499035A0 (es) 1982-09-16
IE801412L (en) 1981-01-09
DK150483C (da) 1987-11-09
NZ194259A (en) 1984-09-28
ES8106302A1 (es) 1981-05-16
AU521014B2 (en) 1982-03-11
DE3067830D1 (en) 1984-06-20
PT71512B (en) 1981-12-11
US4281127A (en) 1981-07-28
NO154426B (no) 1986-06-09
HU184797B (en) 1984-10-29
AU6024480A (en) 1981-03-12
ES8207155A1 (es) 1982-09-16
EP0023594A1 (de) 1981-02-11
FI802195A (fi) 1981-01-10
SG20887G (en) 1988-09-16
YU176680A (en) 1984-12-31
PH16413A (en) 1983-09-29
DK150483B (da) 1987-03-09

Similar Documents

Publication Publication Date Title
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO146392C (no) Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO154396C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.